Ajay K. Gopal - Publications, H-index & Citations

Ajay K. Gopal

fred hutchinson cancer center

65H指数

699论文数

2.0W被引数

收录论文 90

发表时间

Outcomes From the Multicenter ACCRU-LY-1804/CARiBOU TRIAL (Cytarabine, Acalabrutinib and Rituximab Integrated With Bortezomib-Based Outpatient Therapy) in 1st Line Mantle Cell Lymphoma 多中心ACCRU-LY-1804/CARiBOU临床试验（将阿糖胞苷、阿卡替尼和利妥昔单抗整合到 bortezomib为基础的门诊治疗方案中）在一线套细胞淋巴瘤中的结果

American Journal of Hematology

IF9.9

2026-06-17

PREAI

Stephen D. Smith; Suchitra Sundaram; Sharmila Giri; Andy Ness; Yucai Wang; Ajay K. Gopal; Yifan Pang; Emily Tamar Tatoian; Trenton Grossfeld; Ryan C. Lynch; Edus H. Warren; Grzegorz S. Nowakowski; Steven I. Park

“Immunologic Dream Team”: BiTEs peri-allotransplant to redirect donor lymphocytes towards GVL “免疫学梦之队”：移植后供者淋巴细胞导向GVL的BiTEs

Blood Advances

IF7.1

2026-05-22

OAAI

Lorenzo Iovino; Mazyar Shadman; Filippo Milano; Ajay K. Gopal

Pharma steps back from Hodgkin lymphoma: now what?制药公司从霍奇金淋巴瘤领域撤出：接下来怎么办？

Blood Advances

IF7.1

2025-12-09

OAAI

Ryan C. Lynch; Ajay K. Gopal

Barriers to Investigator-Initiated Clinical Trial Enrollment in Frontline Large B-Cell Lymphoma 研究者发起的临床试验在一线大B细胞淋巴瘤患者入组中的障碍

Clinical Lymphoma Myeloma and Leukemia

IF2.7

2025-11-04

OAAI

Carrie Ho; Neena Kennedy; Mengyang Di; Ajay K. Gopal; Ryan C. Lynch; Kevin Ng; Qian V. Wu; Christina Poh; Vikram Raghunathan; Heather Rasmussen; Mazyar Shadman; Brian G. Till; Chaitra S. Ujjani; Stephen D. Smith

Bispecific antibodies in action: the reality of engagement 双特异性抗体在行动：结合的真实情况

Blood

IF23.1

2025-10-30

PREAI

Mazyar Shadman; Ajay K. Gopal

Total Body Irradiation Versus Chemotherapy-Only Conditioning in Autologous Hematopoietic Stem Cell Transplantation for relapsed/refractory Large B-Cell Lymphoma 自体造血干细胞移植治疗复发/难治性大B细胞淋巴瘤中全身照射与单纯化疗预处理方案的比较

Clinical Oncology

IF3

2025-10-14

PREAI

Maryam Ebadi; Xinyi Fan; Gary Schoch; Ted Gooley; Armin Rashidi; Stephen D. Smith; Mazyar Shadman; Leona Holmberg; Chaitra Ujjani; Christina Poh; Vikram Raghunathan; Naveed Ali; Phuong T. Vo; Shivaprasad Manjappa; Manoj Menon; Mengyang Di; Ryan Lynch; Carrie Ho; Brian G. Till; Ralph Ermoian; Ajay K. Gopal; Yolanda D. Tseng

Impact of immunophenotype on clinical disease characteristics and outcomes in T-cell prolymphocytic leukaemia 免疫表型对T细胞原淋巴细胞白血病临床疾病特征和预后的影响

BRITISH JOURNAL OF HAEMATOLOGY

IF3.8

2025-09-01

PREAI

Poh, Christina; Chen, Xueyan; Voutsinas, Jenna; Naresh, Kikkeri; Dizon, Jerlin J.; Shadman, Mazyar; Lynch, Ryan C.; Till, Brian G.; Ujjani, Chaitra S.; Di, Mengyang; Raghunathan, Vikram; Warren, Edus H.; Smith, Stephen D.; Wu, Qian V.; Cherian, Sindhu; Gopal, Ajay K.

CD19 Directed CAR T Therapy for Transformed Follicular Lymphoma: A CIBMTR Analysis CD19靶向CAR T疗法治疗转化型滤泡性淋巴瘤：一项CIBMTR分析

American Journal of Hematology

IF9.9

2025-08-05

PREAI

Swetha Kambhampati Thiruvengadam; Kwang Woo Ahn; Jinalben Patel; Qinghua Lian; Mark Hertzberg; Narendranath Epperla; Leland Metheny; Sanghee Hong; Tania Jain; Mahmoud Aljurf; Amer Beitinjaneh; John Vaughn; Ajay Gopal; Madiha Iqbal; Baldeep Wirk; Shivaprasad Manjappa; Carolina Oliver; Razan Mohty; Mazyar Shadman; Cameron Turtle; Mehdi Hamadani; Alex F. Herrera

Long-term follow-up of dose-dense brentuximab vedotin, ifosfamide, carboplatin and etoposide in second-line treatment of relapsed/refractory classical Hodgkin lymphoma 剂量密集型 Brentuximab vedotin、异环磷酰胺、卡铂和依托泊苷在复发性/难治性经典霍奇金淋巴瘤二线治疗中的长期随访研究

British Journal of Haematology

IF3.8

2025-08-04

PREAI

Ryan C. Lynch; Ryan D. Cassaday; Stephen D. Smith; Andrew J. Cowan; Edus H. Warren; Mazyar S. Shadman; Brian G. Till; Chaitra S. Ujjani; Karolyn Morris; Heather Rasmussen; Jenna Voutsinas; Ajay K. Gopal

Pralatrexate is effective in cytotoxic cutaneous T-cell lymphomas 普利尔替克酸对细胞毒性皮肤T细胞淋巴瘤有效。

Blood Advances

IF7.1

2025-06-19

OAAI

Christina Poh; Jenna M. Voutsinas; Mazyar Shadman; Ryan C. Lynch; Edus H. Warren; Caitlin A. Crimp; Brian G. Till; Chaitra S. Ujjani; Mengyang Di; Vikram Raghunathan; Stephen D. Smith; Qian V. Wu; Michi M. Shinohara; Ajay K. Gopal

Ibrutinib and Venetoclax in Relapsed and Refractory Follicular Lymphoma 伊布替尼和维奈克拉在复发性和难治性滤泡性淋巴瘤中的应用

Clinical Lymphoma Myeloma and Leukemia

IF2.7

2025-04-11

PREAI

Chaitra Ujjani; Hongkun Wang; Catherine Broome; Ajay K Gopal; Stephen D Smith; Catherine Lai; Mazyar Shadman; Lori Leslie; Edus H Warren; Ryan Lynch; Nicole Swanson; Trenton Grossfeld; Bruce D Cheson; Kieron Dunleavy

Nivolumab plus relatlimab for patients with relapsed or progressed B-cell malignancies in RELATIVITY-022 纳武利尤单抗联合罗特利珠单抗治疗复发或进展性B细胞恶性肿瘤的RELATIVITY-022研究

Blood Advances

IF7.1

2025-03-05

OAAI

Ajay K. Gopal; Philippe Armand; Sattva S. Neelapu; Nancy L. Bartlett; Stephen E. Spurgeon; John Kuruvilla; Kerry J. Savage; John P. Leonard; Arnold B. Gelb; Nasir Ahmed; Shiqi Dong; Sai Praneeth Bathena; Rasika Suryawanshi; Jenny Qun Wu; Sheen Wang; Douglas E. Gladstone

Digital Pathology and AI-Based Analysis of P53 Biomarker in Lymphomas: Correlation with Genetic Data 数字病理与基于AI的P53生物标志物在淋巴瘤中的分析：与遗传数据的关联

LABORATORY INVESTIGATION

IF4.2

2025-03-01

PREAI

Naik, Anisha; Kanzaria, Aarti; Kaur, Navneet; Smith, Stephen; Gopal, Ajay; Shadman, Mazyar; Naresh, Kikkeri

Low Rates of Febrile Neutropenia Despite Frequent Grade 4 Neutropenia in Patients Treated with Pembrolizumab plus AVD in Untreated Classic Hodgkin Lymphoma 尽管在接受Pembrolizumab联合AVD治疗的未经治疗经典型霍奇金淋巴瘤患者中频繁出现4级中性粒细胞减少，但发热性中性粒细胞减少的发生率较低。

BLOOD

IF23.1

2024-11-05

PREAI

Kuczmarski, Thomas M.; Ujjani, Chaitra S.; Poh, Christina; Warren, Edus H.; Smith, Stephen D.; Shadman, Mazyar; Till, Brian G.; Raghunathan, Vikram; Tseng, Yolanda D.; Du, Hongyan; Vandermeer, Jacquelin; Kelly, Alyssa; Rasmussen, Heather; Voutsinas, Jenna M.; Gopal, Ajay K.; Lynch, Ryan C.

Impact of Immunophenotype on Clinical Disease Characteristics and Outcomes in T-Cell Prolymphocytic Leukemia T-细胞原淋巴细胞白血病免疫表型对临床疾病特征和预后的影响

BLOOD

IF23.1

2024-11-05

PREAI

Poh, Christina; Chen, Xueyan; Voutsinas, Jenna M.; Warren, Edus H.; Shadman, Mazyar; Lynch, Ryan C.; Till, Brian G.; Ujjani, Chaitra S.; Di, Mengyang; Raghunathan, Vikram; Smith, Stephen D.; Wu, Qian Vicky; Cherian, Sindhu; Gopal, Ajay K.

A Pilot Trial of Low Dose-Mosunetuzumab for Low-Tumor Burden Indolent B-Cell Lymphoma: Trial in Progress 低剂量莫苏尼妥珠单抗治疗低肿瘤负荷惰性B细胞淋巴瘤的初步试验：试验进行中

BLOOD

IF23.1

2024-11-05

PREAI

Ho, Carrie, I; Di, Mengyang; Lynch, Ryan C.; Poh, Christina; Raghunathan, Vikram; Shadman, Mazyar; Smith, Stephen D.; Till, Brian G.; Martin, Paul S.; Ujjani, Chaitra S.; Gopal, Ajay K.

Acalabrutinib and Venetoclax (AV) Combination for 2 Years for Patients with Previously Treated CLL/SLL- the Avenue-2 Trial Acalabrutinib和Venetoclax（AV）联合治疗经治CLL/SLL患者2年——Avenue-2试验

BLOOD

IF23.1

2024-11-05

PREAI

Huang, Jennifer J.; Samples, Laura; Fredericks, Margie; Louie, Stephanie; Pulluru, Ramya; Crider, Christine; Shakib-Azar, Mehrdad; Kennedy, Neena; Raghunathan, Vikram; Poh, Christina; Di, Mengyang; Smith, Stephen D.; Till, Brian G.; Gopal, Ajay K.; Ujjani, Chaitra S.; Lynch, Ryan C.; Shadman, Mazyar

Pralatrexate Is Effective in Cytotoxic Cutaneous T-Cell Lymphomas Pralatrexate 对细胞毒性皮肤T细胞淋巴瘤有效

BLOOD

IF23.1

2024-11-05

PREAI

Poh, Christina; Voutsinas, Jenna M.; Huang, Ivan; Warren, Edus H.; Crimp, Caitlin A.; Shadman, Mazyar; Lynch, Ryan C.; Till, Brian G.; Ujjani, Chaitra S.; Di, Mengyang; Raghunathan, Vikram; Smith, Stephen D.; Wu, Qian Vicky; Shinohara, Michi M.; Gopal, Ajay K.

Analyzing Rates of Exclusion Among Patients Living with HIV in US-Based Non-Hodgkin Lymphoma Clinical Trials from 2014-2024 分析2014-2024年间美国非霍奇金淋巴瘤临床试验中HIV感染者排除率

BLOOD

IF23.1

2024-11-05

PREAI

Olivieri, Daniel J.; Gopal, Ajay K.; Menon, Manoj P.

Quality of Life during Survivorship Following Autologous Stem Cell Transplant for Mantle Cell Lymphoma 自体干细胞移植后滤泡性淋巴瘤生存期的生活质量

BLOOD

IF23.1

2024-11-05

PREAI

Di, Mengyang; Ho, Carrie, I; Smith, Stephen D.; Shadman, Mazyar; Ujjani, Chaitra S.; Lynch, Ryan C.; Poh, Christina; Raghunathan, Vikram; Till, Brian G.; Warren, Edus H.; Gopal, Ajay K.; Lee, Stephanie J.

研究方向